California State Teachers Retirement System (CalSTRS)’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,343
Closed -$321K 3242
2021
Q1
$321K Sell
5,343
-139
-3% -$9.48K ﹤0.01% 2703
2020
Q4
$287K Buy
5,482
+329
+6% +$15.9K ﹤0.01% 2678
2020
Q3
$178K Buy
5,153
+191
+4% +$12.1K ﹤0.01% 2774
2020
Q2
$431K Buy
4,962
+573
+13% +$42.5K ﹤0.01% 2327
2020
Q1
$255K Buy
4,389
+51
+1% +$3.21K ﹤0.01% 2429
2019
Q4
$313K Buy
4,338
+229
+6% +$16.2K ﹤0.01% 2590
2019
Q3
$251K Hold
4,109
﹤0.01% 2694
2019
Q2
$390K Buy
4,109
+214
+5% +$18.2K ﹤0.01% 2499
2019
Q1
$316K Hold
3,895
﹤0.01% 2566
2018
Q4
$633K Buy
3,895
+3,123
+405% +$415K ﹤0.01% 2157
2018
Q3
$126K Hold
772
﹤0.01% 2978
2018
Q2
$116K Buy
+772
New +$113K ﹤0.01% 2980

Other funds holding UBX

California State Teachers Retirement System (CalSTRS)'s UBX Position: Q2 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of Unity Biotechnology (UBX) in Q2 2021, closing a stake of 5,343 shares — an estimated $321K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in UBX in Q2 2018 and held it in 12 quarters. The position peaked at $633K in Q4 2018. 98 funds tracked by Wall St. Rank hold UBX as of Q2 2021.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Unity Biotechnology position as of Q2 2021 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 5,343 Unity Biotechnology shares in Q2 2021, an estimated $321K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Unity Biotechnology in Q2 2018 and held it in 12 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Unity Biotechnology position peaked at $633K in Q4 2018.
  • 98 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2021, filed 16 Aug 2021.